We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jun 2022
  • Code : CMI4949
  • Pages :175
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Injectable pharmaceutical drug delivery system can be used as an alternative to oral drug delivery system. An injection is considered a form of parenteral drug administration, and it allows the medication to be absorbed more rapidly.

Africa injectable drugs market is estimated to be valued at US$ 284.5 Mn in 2022 and expected to exhibit a CAGR of 4.7% during the forecast period (2022-2030).

Figure 1. Africa Injectable Drugs Market Share (%) in Terms of Value, by Molecule Type, 2022

AFRICA INJECTABLE DRUGS MARKET

To learn more about this report, request a free sample copy

The increasing prevalence of chronic diseases such as cardiovascular, diabetes, cancer, etc. is expected to drive the market growth during the forecast period.

Sedentary lifestyle and changes in dietary habits i.e. the consumption of fats and sugar-rich diet lead to an increase in cases of obesity and thereby increase the risk of cardiovascular diseases and diabetes. For instance, according to the International Diabetes Federation, in 2019, an estimated 19.4 million adults aged 20-79 years were living with diabetes in Africa.

Africa Injectable Drugs Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 284.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 4.7% 2030 Value Projection: US$ 410.9 Mn
Geographies covered:
  • Africa: North Africa, Central Africa, and South Africa
Segments covered:
  • By Molecule Type: Large Molecule, Small Molecule
  • By Route of Administration: Intravenous, Intramuscular, Sub-cutaneous, Others
  • By End User: Hospitals, Specialty Clinics, Others
Companies covered:

Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh,  Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Growth Drivers:
  • Increase in the prevalence of chronic diseases
  • Growing manufacturing facilities for pharmaceutical drugs
Restraints & Challenges:
  • Lack of funding for manufacturing injectable products

Figure 2. Africa Injectable Drugs Market Share (%), by End User, 2022

AFRICA INJECTABLE DRUGS MARKET

To learn more about this report, request a free sample copy

Growing manufacturing facilities for pharmaceutical drugs are expected to drive the market growth during the forecast period.

The ever-growing number of healthcare practitioners leads to a surge in the demand for injectable drugs. For instance, in Africa estimated there were about 266,279 doctors in 2020. Thus, key market players are engaged in enhancing their manufacturing capabilities and strengthening their position in the market, which will drive the market growth. For instance, in sub-Saharan Africa, only Kenya, Nigeria, and South Africa have a relatively considerable industry with a significant number of manufacturing companies. Moreover, initiatives by governments and market players to develop a local drug industry in sub-Saharan Africa is expected to create a significant opportunity for the market players.

Africa Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization (WHO) declared it a public health emergency on January 30, 2020.

The COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets.

Africa Injectable Drugs Market: Restraint

The major factors that hinder the growth of Africa injectable drugs market include the lack of funding for manufacturing injectable products. Lack of finances can also be a significant challenge to manufacturing injectable pharmaceuticals.

Key Players

Major players operating in Africa injectable drugs market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Frequently Asked Questions

Africa injectable drugs market is estimated to be valued at US$ 284.5 million in 2022 and expected to exhibit a CAGR of 4.7% between 2022 and 2030.

Factors such as an increase in the prevalence of chronic disease and number of manufacturing facilities are expected to drive the market growth during the forecast period.

Small molecule is the leading molecule type segment and is expected to hold a major market share during the forecast period.

The major factors hampering the growth of the market include the lack of funding for manufacturing injectable products.

Major players operating in the market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo